Baricitinib Tablet, Film Coated
NDC Package 0002-6885-30

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Baricitinib tablets is baricitinib is used to treat rheumatoid arthritis. This formulation utilizes a tablet, film coated delivery system. Marketed by Eli Lilly And Company, this product is identified by NDC 0002-6885.

Identification & Billing

NDC Package Code
0002-6885-30
Package Description
30 TABLET, FILM COATED in 1 BOTTLE
Product Code
0002-6885
11-Digit Billing Format
00002688530
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Baricitinib
Non-Proprietary Name
Baricitinib
Substance Name
Baricitinib
Dosage Form
Tablet, Film Coated - A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
BARICITINIB 4 mg/1
Pharmacologic Class
Usage Information
Baricitinib is used to treat rheumatoid arthritis. It helps decrease pain, tenderness, and swelling in the joints.

Regulatory & Marketing

Labeler Name
Eli Lilly And Company
Product Type
Human Prescription Drug
Marketing Category
EMERGENCY USE AUTHORIZATION -
Start Marketing Date
12-20-2021
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0002-6885-30 identifies a specific commercial package of 30 tablet, film coated in 1 bottle of Baricitinib, a human prescription drug labeled by Eli Lilly And Company. This tablet, film coated is formulated for oral use and contains baricitinib as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Eli Lilly And Company on December 20, 2021. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

Baricitinib is used to treat rheumatoid arthritis. It helps decrease pain, tenderness, and swelling in the joints.

How is this Eli Lilly And Company product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00002688530. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0002-6885-30
11-Digit CMS (5-4-2)
00002-6885-30

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.